These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7628340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC.
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [Abstract] [Full Text] [Related]

  • 7. [Depressive symptoms and negative symptoms during schizophrenia].
    Dollfus S, Langlois S, Assouly-Besse F, Petit M.
    Encephale; 1995 Jun; 21 Spec No 3():23-7. PubMed ID: 7628337
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathophysiology and treatment of negative symptoms.
    Villeneuve A.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [Abstract] [Full Text] [Related]

  • 12. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I, Langlois-Thery S, Dollfus S, Petit M.
    Encephale; 1997 Nov; 23(4):267-72. PubMed ID: 9417392
    [Abstract] [Full Text] [Related]

  • 13. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [Abstract] [Full Text] [Related]

  • 14. [Clozapine and treatment of negative symptoms].
    Lançon C, Farisse J, Llorca PM.
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [Abstract] [Full Text] [Related]

  • 15. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC, Lung FW, Chong MY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [Abstract] [Full Text] [Related]

  • 16. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H, Bourgeois M.
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T.
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [Abstract] [Full Text] [Related]

  • 19. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
    Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC.
    Biol Psychiatry; 1996 Feb 01; 39(3):213-5. PubMed ID: 8837983
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.